New orally active cephalosporin esters.
Yamada
H
H
Research & Development Division, Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.
Ueda
S
S
Mutoh
M
M
Nagata
H
H
Nouda
H
H
Fukasawa
M
M
Okuda
T
T
D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D020682:Cefixime; D015281:Cefmenoxime / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004952:Esters; D051379:Mice; D051381:Rats
D002511:Cephalosporins; D004952:Esters; C046817:cefteram pivoxil; D020682:Cefixime; D015281:Cefmenoxime; D002439:Cefotaxime